AU6926101A - Method of making particles for use in a pharmaceutical composition - Google Patents

Method of making particles for use in a pharmaceutical composition

Info

Publication number
AU6926101A
AU6926101A AU6926101A AU6926101A AU6926101A AU 6926101 A AU6926101 A AU 6926101A AU 6926101 A AU6926101 A AU 6926101A AU 6926101 A AU6926101 A AU 6926101A AU 6926101 A AU6926101 A AU 6926101A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
making particles
particles
making
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU6926101A
Other languages
English (en)
Inventor
John Nicholas Staniforth
David Alexander Vodden Morton
Rosella Musa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectura Ltd
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0029263A external-priority patent/GB0029263D0/en
Priority claimed from PCT/GB2001/001732 external-priority patent/WO2001078694A2/en
Application filed by Vectura Ltd filed Critical Vectura Ltd
Priority claimed from PCT/GB2001/002860 external-priority patent/WO2002000197A1/en
Publication of AU6926101A publication Critical patent/AU6926101A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU6926101A 2000-06-27 2001-06-27 Method of making particles for use in a pharmaceutical composition Pending AU6926101A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00113608 2000-06-27
GB0029263A GB0029263D0 (en) 2000-11-30 2000-11-30 Method of making particles for use in a pharmaceutical composition
PCT/GB2001/001732 WO2001078694A2 (en) 2000-04-17 2001-04-17 Formulations for use in inhaler devices
PCT/GB2001/002860 WO2002000197A1 (en) 2000-06-27 2001-06-27 Method of making particles for use in a pharmaceutical composition

Publications (1)

Publication Number Publication Date
AU6926101A true AU6926101A (en) 2002-01-08

Family

ID=27223055

Family Applications (2)

Application Number Title Priority Date Filing Date
AU6926101A Pending AU6926101A (en) 2000-06-27 2001-06-27 Method of making particles for use in a pharmaceutical composition
AU2001269261A Expired AU2001269261B2 (en) 2000-06-27 2001-06-27 Method of making particles for use in a pharmaceutical composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001269261A Expired AU2001269261B2 (en) 2000-06-27 2001-06-27 Method of making particles for use in a pharmaceutical composition

Country Status (5)

Country Link
JP (1) JP5698423B2 (enExample)
AU (2) AU6926101A (enExample)
CA (1) CA2413692C (enExample)
DE (1) DE60131399T3 (enExample)
DK (1) DK1296651T3 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5288791B2 (ja) * 2005-01-28 2013-09-11 武田薬品工業株式会社 難水溶性物質含有微細化組成物
ITMI20051999A1 (it) * 2005-10-21 2007-04-22 Eratech S R L Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
KR20130062268A (ko) * 2010-04-21 2013-06-12 키에시 파르마슈티시 엣스. 피. 에이. 정전하가 감소된 입자를 제공하는 방법
ES2814336T3 (es) * 2012-04-13 2021-03-26 Glaxosmithkline Ip Dev Ltd Partículas de agregado
PT3019153T (pt) * 2013-07-11 2018-12-04 Chiesi Farm Spa Formulação de pó seco que compreende um anticolinérgico, um corticosteroide e um beta-adrenérgico para administração por inalação
MA40910A (fr) * 2014-11-07 2017-09-12 Civitas Therapeutics Inc Poudres de rapamycine pour administration pulmonaire
WO2019009335A1 (ja) * 2017-07-04 2019-01-10 村上　正裕 微粒子の製造方法及び微粒子

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
DE3917617A1 (de) * 1989-05-31 1990-12-06 Boehringer Ingelheim Kg Mikronisierte bioabbaubare partikel, verfahren zur ihrer herstellung und ihre verwendung
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
WO1998031346A1 (en) * 1997-01-16 1998-07-23 Massachusetts Institute Of Technology Preparation of particles for inhalation
AU749623B2 (en) * 1998-03-26 2002-06-27 Astellas Pharma Inc. Sustained release preparations
DK1131059T3 (da) * 1998-11-13 2003-06-30 Jago Res Ag Tørpulver til inhalation
GB9826783D0 (en) * 1998-12-04 1999-01-27 Scherer Ltd R P Inhalation powders
GB9827145D0 (en) * 1998-12-09 1999-02-03 Co Ordinated Drug Dev Improvements in or relating to powders

Also Published As

Publication number Publication date
DE60131399T3 (de) 2019-11-14
JP2004501183A (ja) 2004-01-15
DE60131399D1 (de) 2007-12-27
JP5698423B2 (ja) 2015-04-08
CA2413692A1 (en) 2002-01-03
DK1296651T3 (da) 2008-02-11
DE60131399T2 (de) 2008-04-17
AU2001269261B2 (en) 2005-11-17
CA2413692C (en) 2011-10-18

Similar Documents

Publication Publication Date Title
AU2211502A (en) Method of making particles for use in a pharmaceutical composition
IL153282A0 (en) Method for preparing a pharmaceutical composition
GB2387709B (en) Method for utilizing oral movement and related events
EP1341864A4 (en) PROCESS FOR PRODUCING ABRASIVE COMPOSITIONS AND PRODUCTS OBTAINED
IL154008A0 (en) New pharmaceutical composition
HUP0003111A3 (en) Pharmaceutical compositions containing methylsulfonylamino pyrimidin derivative and process for their preparation
HUP0302499A3 (en) Pharmaceutical compositions of estrogen-cyclodextrin complexes and process for their preparation
AU7801601A (en) Cleaning composition and methods for manufacturing and using
AU7013501A (en) Methods and composition for oral vaccination
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
HUP0300539A3 (en) New pharmaceutical composition in form of emulsion preconcentrate
HUP0302099A3 (en) Azythromycin in the form of a monohydrate, process for its preparation and pharmaceutical composition containing in the monohydrate form
IL145188A0 (en) Processes for making pharmaceutical oral ecb formulations and compositions
AU6926101A (en) Method of making particles for use in a pharmaceutical composition
IL153487A0 (en) Pharmaceutical compositions and methods for use
GB2377888B (en) Sustained release pharmaceutical composition containing glipizide and method for producing same
HUP0105410A3 (en) New metalloproteinase inhibitors, a process for their preparation and pharmaceutical compositions containing them
IL153897A0 (en) Pharmaceutical compositions and methods for use
HU0101222D0 (en) Mannite in powder form and process for producing thereof
HUP0301110A3 (en) Stabilised radiopharmaceuticals and process for their preparation
HUP9902559D0 (en) Pharmaceutical composition and process for producing it
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
GB0029261D0 (en) Method of making particles for use in a pharmaceutical composition
GB0030946D0 (en) Method of making particles for use in a pharmaceutical composition
GB0029263D0 (en) Method of making particles for use in a pharmaceutical composition